SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-050049
Filing Date
2020-04-23
Accepted
2020-04-23 09:00:41
Documents
12
Period of Report
2020-06-10
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm202033-1_def14.htm DEF 14A 608755
2 GRAPHIC sg_armandoanido-bw.jpg GRAPHIC 72611
3 GRAPHIC tm202033d1_icon-memberbw.jpg GRAPHIC 5764
4 GRAPHIC tm202033d1_icon-chaircombw.jpg GRAPHIC 6637
5 GRAPHIC tm202033d1_icon-femalechbw.jpg GRAPHIC 5010
6 GRAPHIC tm202033d1_icon-commitbw.jpg GRAPHIC 11928
7 GRAPHIC tm202033d1_icon-chair2bw.jpg GRAPHIC 9707
8 GRAPHIC tm202033d1_icon-mailbw.jpg GRAPHIC 54371
9 GRAPHIC tm202033d1_icon-internetbw.jpg GRAPHIC 47060
10 GRAPHIC tm202033d1_icon-telephonebw.jpg GRAPHIC 46263
11 GRAPHIC tm202033d1_pc-page1bw.jpg GRAPHIC 572043
12 GRAPHIC tm202033d1_pc-page2bw.jpg GRAPHIC 337709
  Complete submission text file 0001104659-20-050049.txt   2221495
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37526 | Film No.: 20809386
SIC: 2834 Pharmaceutical Preparations